Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for 89Zr-immunoPET"

Additional information on "Direct comparison of the in vitro and in vivo stability of DFO, DFO* and DFOcyclo* for ⁸⁹Zr-immunoPET"

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):505-506. doi: 10.1007/s00259-019-04561-8. Epub 2019 Nov 9.

¹ Department of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands.
² Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France.
³ Global Research Technologies, Novo Nordisk A/S, Novo Nordisk Park, DK-2760, Måløv, Denmark.
⁴ Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France. jcchambron@unistra.fr.
⁵ Institut de Chimie de Strasbourg, UMR 7177, CNRS, Université de Strasbourg, 1 rue Blaise Pascal, 67008, Strasbourg Cedex, France. jcchambron@unistra.fr.
⁶ Department of Radiology and Nuclear Medicine, Radboud Institute for Molecular Life Sciences, Radboud UMC, Nijmegen, The Netherlands. Sandra.Heskamp@radboudumc.nl.
⁷ Institut de Chimie Moléculaire de l'Université de Bourgogne, UMR 6302, CNRS, Université Bourgogne Franche-Comté, 9 avenue A. Savary, 21078, Dijon Cedex, France. franck.denat@u-bourgogne.fr.

No abstract available